Kevin R Woller

This inventor holds 29 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbvie Inc., Arqule, Inc., Wyeth. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin R Woller. Retrieved from https://idiyas.com/inventor/kevin-r-woller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 20)

% Patents Active = 75.9

CIPO Patents = 4 (Patent Applications = 12)

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 11.5

ph-index = 9

Forward Citations = 341(Granted Patents)

Location History:

Ayer, MA (US) (2003 - 2010)
Anitoch, IL (US) (2014)
Antioch, IL (US) (2010 - 2018)

Company Filing History:

Abbott Laboratories Corporation

6. 2 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Pyrimidines

Bruton's Tyrosine Kinase

NAMPT Inhibitors

ROCK Inhibitors

Anti-Viral Compounds

Tricyclic Compounds

Bromodomain Inhibitors

TRPV1 Antagonists

Calcium Channel Blockers

Heterocyclic Sulfonamides

Oxadiazole Compounds

Beta Amyloid Production

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12172992 - Pyrimidines for degrading Bruton's tyrosine kinase (2024-12-24),

2. 10093624 - NAMPT and ROCK inhibitors (2018-10-09),

3. 10039754 - Anti-viral compounds (2018-08-07),

4. 10028937 - Anti-viral compounds (2018-07-24),

5. 9777020 - Furo-3-carboxamide derivatives and methods of use (2017-10-03),

6. 9586978 - Anti-viral compounds (2017-03-07),

7. 9365579 - Tricyclic compounds (2016-06-14),

8. 9302989 - NAMPT and rock inhibitors (2016-04-05),

9. 9050346 - Bromodomain inhibitors (2015-06-09),

10. 9012651 - TRPV3 modulators (2015-04-21),

11. 9006387 - Anti-viral compounds (2015-04-14),

12. 8975398 - NAMPT inhibitors (2015-03-10),

13. 8969325 - TRPV1 antagonists (2015-03-03),

14. 8962629 - Tricyclic compounds (2015-02-24),

15. 8937150 - Anti-viral compounds (2015-01-20),

Title: The Innovative Journey of Kevin R Woller

Introduction: Kevin R Woller, a talented inventor hailing from Antioch, IL (US), has made significant contributions to the world of innovation through his creative and groundbreaking ideas.

Latest Patents: Kevin R Woller's latest patents showcase his ingenuity in various fields, including technology, engineering, and design. His recent inventions have been recognized for their unique approach and practical applications.

Career Highlights: Throughout his illustrious career, Kevin R Woller has demonstrated a keen eye for identifying gaps in the market and developing innovative solutions to address them. His passion for creating new technologies has led to the successful commercialization of several groundbreaking products.

Collaborations: Kevin R Woller has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Kevin R Woller's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.